The FDA and Cancer Treatments

Riley Drake, Editor in Chief
April 11, 2012

Recent shortages of two cancer drugs, preservative-free methotrexate and Doxil, have threatened the lives and health of patients whose lives depend on these drugs (The Guardian).  The first drug, preservative-free methotrexate, is vital to the treatment of children with leukemia, specifically, acute... Read more »